Issue 3/2015
Content (20 Articles)
Can hypersplenism secondary to portal hypertension be treated by non-selective beta blockers?
Moon Young Kim, Yasuko Iwakiri
20-year survival post-liver transplant: much more is needed!
Russell Strong, Jonathan Fawcett
Model for end-stage liver disease score and MELD exceptions: 15 years later
Sumeet K. Asrani, Patrick S. Kamath
Criteria for liver transplantation in ACLF and outcome
Albert Chi Yan Chan, Sheung Tat Fan
Definition of ACLF and inclusion criteria for extra-hepatic organ failure
Xiaojing Wang, Shiv Kumar Sarin, Qin Ning
Pattern and profile of chronic liver disease in acute on chronic liver failure
Zaigham Abbas, Lubna Shazi
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure
Man-Fung Yuen
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
Heather Bennett, Nathalie Waser, Karissa Johnston, Jia-Horng Kao, Young-Suk Lim, Zhong-Ping Duan, Youn-Jae Lee, Lai Wei, Chien-Jen Chen, William Sievert, Yong Yuan, Hong Li
Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes
Bin Chen, Weiping Wang, Matthew D. Tam, Cristiano Quintini, John J. Fung, Xiao Li
Twist in hepatocellular carcinoma: pathophysiology and therapeutics
Hui Zou, Xing Feng, Jian-Guo Cao
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
Niels van Best, Peter L. Jansen, Sander S. Rensen
Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis
Zuxiong Huang, Chun Lin, Jiankai Fang, Ning Wang, Rui Zhou, Chen Pan
HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b
Yosuke Hirotsu, Tatsuo Kanda, Hiroshi Matsumura, Mitsuhiko Moriyama, Osamu Yokosuka, Masao Omata
Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
Pardha Devaki, David Jencks, Brittany E. Yee, Mindie H. Nguyen
Multiple genes identified as targets for 20q13.12–13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma
Dong Wang, Zhong-Zheng Zhu, Hongmei Jiang, Jiayi Zhu, Wen-Ming Cong, Bing-Ji Wen, Song-Qin He, Shu-Fang Liu
β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children
Ujjal Poddar, Upender Shava, Surender Kumar Yachha, Jaya Agarwal, Sheo Kumar, Sanjay S. Baijal, Anshu Srivastava
Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients
Amir Taefi, Chun-Chih Huang, Kirthi Kolli, Suzan Ebrahimi, Mitesh Patel
Analysis of adult 20-year survivors after liver transplantation
C. Dopazo, I. Bilbao, L. L. Castells, G. Sapisochin, C. Moreiras, I. Campos-Varela, J. Echeverri, M. Caralt, J. L. Lázaro, R. Charco
Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease
Sahar Mohamed El-Haggar, Tarek Mohamed Mostafa